Breadcrumb
  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey

Health Center COVID-19 Survey

View addendum to Health Center COVID-19 Survey Tool Questions and related user guide for participating health centers in the Health Center COVID-19 Vaccine Program.

National Summary Report

Latest data from September 9, 2022

HRSA uses the information collected to: optimize COVID-19 testing and vaccination; track health center capacity and the impact of COVID-19 on operations, patients, and staff; and better understand training and technical assistance, funding, and other health center resource needs.

Health Center COVID-19 Survey Tool Questions

Health Center COVID-19 Survey Tool User Guide

Health Center Program Look-Alike Survey Data for COVID-19

COVID-19 Health Center Survey Interactive Data Dashboards

View cumulative vaccination data nationally; by state, territory, and freely associated state; and among patients identified as racial and/or ethnic minorities. New data views: total vaccinations (all sources) and Health Center Vaccine Program (federal allocations only).

View operational data, including testing capacity, vaccinations initiated and completed, temporary closures, staff ability to work, and visits conducted virtually.

View COVID-19 testing data by race/ethnicity.

Note: The dashboard data are updated weekly using Health Center COVID-19 Survey data.

Number of Health Center respondents = 1019 (74% of all Health Centers)

Data represent information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 166,258
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 61.61%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 27,111
Racial and/or Ethnic Minority Patients 53.11%

Patients Tested by Race and Ethnicity

Race/Ethnicity Patients Tested by race and ethnicity, Virus Detection (PCR, antigen)2 Patients Tested Positive by race and ethnicity, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 34.98% 42.34%
White, Hispanic/Latino Patients 25.61% 21.39%
Black/African American, Non-Hispanic/Latino Patients 12.95% 10.93%
Black/African American, Hispanic/Latino Patients 1.17% 0.90%
Asian Patients3 2.14% 2.39%
American Indian/Alaska Native Patients3 1.44% 1.16%
Native Hawaiian/Other Pacific Islander Patients3 1.86% 0.79%
Patients with More Than One Race3 3.73% 4.56%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 7.24% 5.85%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.09% 1.84%
Unreported/Refused to Report Race and Ethnicity 6.81% 7.86%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 20,363
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 83.21%
COVID-19 Immunization Series Completed 22,292
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 83.88%
COVID-19 Immunization Series Additional 35,393
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 75.38%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 14.81% 14.58% 22.11%
White, Hispanic/Latino Patients 35.42% 32.52% 22.76%
Black/African American, Non-Hispanic/Latino Patients 12.75% 8.86% 15.22%
Black/African American, Hispanic/Latino Patients 1.00% 0.79% 0.66%
Asian Patients3 5.19% 6.49% 8.59%
American Indian/Alaska Native Patients3 1.14% 0.79% 2.27%
Native Hawaiian/Other Pacific Islander Patients3 2.69% 3.08% 2.23%
Patients with More Than One Race3 2.96% 2.68% 7.74%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 12.25% 20.67% 8.19%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.30% 2.28% 2.07%
Unreported/Refused to Report Race and Ethnicity 9.50% 7.27% 8.14%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 25.81%
1 to 24 Hours 34.45%
More Than 24 Hours 37.88%
N/A 1.86%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 5.30%
Staffing to administer the vaccine 24.93%
Vaccine confidence 30.42%
Vaccine storage capacity 2.36%
Vaccine supply 3.53%
Other 7.07%
None 43.96%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 28.66%
Average Percent of Health Center Visits Conducted Virtually 13.79%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 21.98%
Number of Mobile Van Sites 298
Number of Pop-up Clinics 442
Number of School-Based Vaccination Sites 157
Number of Family Vaccination Clinics 808

Monoclonal Antibody Therapy

Metrics Value
Percent of Health Centers Providing Access to Monoclonal Antibody Therapy 62.71%
Number of Doses of Monoclonal Antibodies Administered 579

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 8.44%
Refer patients to another organization that provides monoclonal antibody therapies 55.54%
None 37.29%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 9.32%
Patient awareness/education 5.30%
Staffing capacity 15.01%
Therapy administration/onsite logistics 15.60%
Other 6.18%
None 62.71%

Test Kit Distribution

Metrics Value
Percent of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 60.35%
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 375,928

Test Kit Distribution Methods4

Metrics Value
Provided to Existing Health Center Patients 87.48%
Provided to General Public Who Came to the Health Center 56.59%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 19.84%
Provided at Other Community Events 28.94%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 10.24%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 18.05%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 14.47%
Provided to school-age children and/or their families directly or through partnerships with schools 15.61%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 11.06%
Other 8.13%

N95 Mask Distribution

Metrics Value
Percent of Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask 31.40%
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 241,279

N95 Mask Distribution Methods5

Metrics Value
Provided to Existing Health Center Patients 88.12%
Provided to General Public Who Came to the Health Center 60.31%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 22.50%
Provided at Other Community Events 31.25%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 12.50%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 19.69%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 17.19%
Provided to school-age children and/or their families directly or through partnerships with schools 17.81%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 13.44%
Other 4.69%

Oral Antiviral Medication Distribution

Metrics Value
Percent of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 27.48%
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 47.78%

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 41.36%
White, Hispanic/Latino Patients 17.93%
Black/African American, Non-Hispanic/Latino Patients 11.48%
Black/African American, Hispanic/Latino Patients 1.18%
Asian Patients3 4.81%
American Indian/Alaska Native Patients3 0.83%
Native Hawaiian/Other Pacific Islander Patients3 0.27%
Patients with More Than One Race3 4.36%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 6.91%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.59%
Unreported/Refused to Report Race and Ethnicity 9.28%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 2.50%
Patients Experiencing Homelessness 1.69%
Patients Who Are Residents of Public Housing 5.70%
Patients with Limited English Proficiency 12.13%
Children Under 18 Years of Age 2.45%

Results from States and Territories

Select a measure on the dropdown menu to view by state or territory.

 


1 The reported number of patients tested does not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.

Date Last Reviewed: